https://www.marketwatch.com/press-release/fda-expediting-accelerated-development-of-novel-therapies-for-covid-19-2020-04-28
- Forums
- ASX - By Stock
- MSB
- FDA Expediting Accelerated Development of Novel Therapies for COVID-19
MSB
mesoblast limited
Add to My Watchlist
4.15%
!
$2.31

FDA Expediting Accelerated Development of Novel Therapies for COVID-19
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.31 |
Change
-0.100(4.15%) |
Mkt cap ! $3.084B |
Open | High | Low | Value | Volume |
$2.33 | $2.33 | $2.27 | $1.641M | 705.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 998 | $2.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.31 | 6088 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 15010 | 2.330 |
8 | 31492 | 2.320 |
11 | 33479 | 2.310 |
15 | 60810 | 2.300 |
6 | 11644 | 2.290 |
Price($) | Vol. | No. |
---|---|---|
2.340 | 516 | 2 |
2.350 | 23813 | 9 |
2.360 | 45890 | 10 |
2.370 | 28518 | 6 |
2.380 | 7851 | 4 |
Last trade - 10.00am 21/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |